Abstract
We have studied the effect of solubilising N-terminal fusion proteins on the yield of target protein after removal of the fusion partner and subsequent purification using immobilised metal ion affinity chromatography. We compared the yield of 45 human proteins produced from four different expression vectors: three having an N-terminal solubilising fusion protein (the GB1-domain, thioredoxin, or glutathione S-transferase) followed by a protease cleavage site and a His tag, and one vector having only an N-terminal His tag. We have previously observed a positive effect on solubility for proteins produced as fusion proteins compared to proteins produced with only a His tag in Escherichia coli. We find this effect to be less pronounced when we compare the yields of purified target protein after removal of the solubilising fusion although large target-dependent variations are seen. On average, the GB1+His fusion gives significantly higher final yields of protein than the thioredoxin+His fusion or the His tag, whereas GST+His gives lower yields. We also note a strong correlation between solubility and target protein size, and a correlation between solubility and the presence of peptide fragments that are predicted to be natively disordered.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- eGFP:
-
enhanced green fluorescent protein
- GST:
-
glutathione S-transferase
- IMAC:
-
immobilised metal ion affinity chromatography
- MBP:
-
maltose binding protein
- MES:
-
2-(N-morpholino) ethanesulfonic acid
- Ni-NTA:
-
Ni2+-nitrilotriacetic acid
- ORF:
-
open reading frame
- RBS:
-
ribosome binding site
References
Waugh D.S. (2005) Trends Biotechnol. 23: 316–320
Hammarström M., Hellgren N., van den Berg S., Berglund H. and Härd T. (2002) Protein Sci. 11: 313–21
Braun P., Hu Y., Shen B., Halleck A., Koundinya M., Harlow E. LaBaer J. (2002) Proc. Natl. Acad. Sci. U S A 99: 2654–9
Shih Y.P., Kung W.M., Chen J.C., Yeh C.H., Wang A.H., Wang T.F. (2002) Protein Sci. 11: 1714–9
Dyson M.R., Shadbolt S.P., Vincent K.J., Perera R.L., McCafferty J. (2004) BMC Biotechnol. 4: 32
Woestenenk E.A., Hammarström M., van den Berg S., Härd T., Berglund H. (2004) J. Struct. Funct. Genomics 5: 217–229
Smith D.B., Johnson K.S. (1988) Gene 67: 31–40
LaVallie E.R., DiBlasio E.A., Kovacic S., Grant K.L., Schendel P.F. and McCoy J.M. (1993) Biotechnology (N Y) 11: 187–93
Huth J.R., Bewley C.A., Jackson B.M., Hinnebusch A.G., Clore G.M. and Gronenborn A.M. (1997) Protein Sci. 6: 2359–64
Bedouelle H. and Duplay P. (1988) Eur. J. Biochem. 171: 541–9
di Guan C., Li P., Riggs P.D. and Inouye H. (1988) Gene 67: 21–30
Davis G.D., Elisee C., Newham D.M., Harrison R.G. (1999) Biotechnol. Bioeng. 65: 382–8
Sachdev D. and Chirgwin J.M. (1999) J. Protein Chem. 18: 127–36
Nominé Y., Ristriani T., Laurent C., Lefèvre J.F., Weiss E. and Travé G. (2001) Protein Expr. Purif. 23: 22–32
Ashraf S.S., Benson R.E., Payne E.S., Halbleib C.M., Grøn H. (2004) Protein Expr. Purif. 33: 238–45
Lechner M.S. and Laimins L.A. (1994) J. Virol. 68: 4262–73
Kapust R.B. and Waugh D.S. (2000) Protein Expr. Purif. 19: 312–8
Woestenenk E.A., Hammarström M., Härd T., Berglund H. (2003) Anal. Biochem. 318: 71–9
Braun P. and LaBaer J. (2003) Trends Biotechnol. 21: 383–8
Busso D., Kim R. and Kim S.H. (2004) J. Struct. Funct. Genomics 5: 69–74
Chambers S.P., Austen D.A., Fulghum J.R., Kim W.M. (2004) Protein Expr. Purif. 36: 40–7
Savchenko A., Yee A., Khachatryan A., Skarina T., Evdokimova E., Pavlova M., Semesi A., Northey J., Beasley S., Lan N., Das R., Gerstein M., Arrowmith C.H., Edwards A.M. (2003) Proteins 50: 392–9
Scheich C., Sievert V., Büssow K. (2003) BMC Biotechnol. 3: 12
Trésaugues L., Collinet B., Minard P., Henckes G., Aufrère R., Blondeau K., Liger D., Zhou C.Z., Janin J., Van Tilbeurgh H., Quevillon-Cheruel S. (2004) J. Struct. Funct. Genomics 5: 195–204
Goh C.S., Lan N., Douglas S.M., Wu B., Echols N., Smith A., Milburn D., Montelione G.T., Zhao H., Gerstein M. (2004) J. Mol. Biol. 336: 115–30
Wang W., Malcolm B.A. (1999) Biotechniques 26: 680–2
Bateman A., Coin L., Durbin R., Finn R.D., Hollich V., Griffiths-Jones S., Khanna A., Marshall M., Moxon S., Sonnhammer E.L., Studholme D.J., Yeats C. and Eddy S.R. (2004) Nucleic Acids Res. 32 Database issue : D138–41
Zhang G., Gurtu V., Kain S.R. (1996) Biochem. Biophys. Res. Commun. 227: 707–11
Bradford M.M. (1976) Anal. Biochem. 72: 248–54
Etchegaray J.P. and Inouye M. (1999) J. Bacteriol. 181: 5852–4
Stenström C.M., Jin H., Major L.L., Tate W.P., Isaksson L.A. (2001) Gene 263: 273–84
Christendat D., Yee A., Dharamsi A., Kluger Y., Savchenko A., Cort J.R., Booth V., Mackereth C.D., Saridakis V., Ekiel I., Kozlov G., Maxwell K.L., Wu N., McIntosh L.P., Gehring K., Kennedy M.A., Davidson A.R., Pai E.F., Gerstein M., Edwards A.M. and Arrowsmith C.H. (2000) Nat. Struct. Biol. 7: 903–9
Lesley S.A., Kuhn P., Godzik A., Deacon A.M., Mathews I., Kreusch A., Spraggon G., Klock H.E., McMullan D., Shin T., Vincent J., Robb A., Brinen L.S., Miller M.D., McPhillips T.M., Miller M.A., Scheibe D., Canaves J.M., Guda C., Jaroszewski L., Selby T.L., Elsliger M.A., Wooley J., Taylor S.S., Hodgson K.O., Wilson I.A., Schultz P.G. Stevens R.C. (2002) Proc. Natl. Acad. Sci. U S A 99: 11664–9
Yokoyama S. (2003) Curr. Opin. Chem. Biol. 7: 39–43
Scheich C., Leitner D., Sievert V., Leidert M., Schlegel B., Simon B., Letunic I., Büssow K., Diehl A. (2004) BMC Struct. Biol. 4: 4
Linding R., Jensen L.J., Diella F., Bork P., Gibson T.J. and Russell R.B. (2003) Structure 11: 1453–9
Uversky V.N., Gillespie J.R., Fink A.L. (2000) Proteins 41: 415–27
Kapust R.B. and Waugh D.S. (1999) Protein Sci. 8: 1668–74
Lu Z., DiBlasio-Smith E.A., Grant K.L., Warne N.W., LaVallie E.R., Collins-Racie L.A., Follettie M.T., Williamson M.J. and McCoy J.M. (1996) J Biol Chem 271: 5059–65
Hirel P.H., Schmitter M.J., Dessen P., Fayat G., Blanquet S. (1989) Proc. Natl. Acad. Sci. U S A 86: 8247–51
Read S.M. and Northcote D.H. (1981) Anal. Biochem. 116: 53–64
Acknowledgements
We would like to acknowledge the contributions of John Löfblom and Kristina Bergström for initial cloning of genes 202 to 215, Harry Brumer and Hongbin Henriksson for the mass spectrometry analysis and Susanne van den Berg for construction of the vectors pTH8 and pTH18. This work was supported by the European Commission Integrated Project SPINE (QLG2-CT-2002-00988) as part of the Framework 5 Quality of Life and Management of Living Resources Program, by the Wallenberg Consortium North (WCN) and by the Swedish foundation for strategic research (SSF).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Hammarström, M., Woestenenk, E.A., Hellgren, N. et al. Effect of N-terminal solubility enhancing fusion proteins on yield of purified target protein. J Struct Funct Genomics 7, 1–14 (2006). https://doi.org/10.1007/s10969-005-9003-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10969-005-9003-7